CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients
24. Oktober 2024 17:50 ET
|
Natural Alternatives International Inc
CARLSBAD, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), are pleased to announce a new distribution...
CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism
26. August 2024 08:00 ET
|
Natural Alternatives International Inc
Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands will exhibit at the 46th ESPEN Congress on Clinical Nutrition & Metabolism in Milan...
USD 44 Bn Medical Foods Market to Grow at a CAGR of 7.5% During 2023 to 2031 | Transparency Market Research
29. März 2023 15:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, March 30, 2023 (GLOBE NEWSWIRE) -- According to market research conducted by TMR, the global medical foods industry was valued at USD 23.0 Bn in 2022 and is...
Changing Lifestyle to Enhance Consumption of Oral Medical Food Products, Likely to Surpass US$ 11 Billion by 2032: Fact.MR Study
21. Juni 2022 22:00 ET
|
FACT.MR
United States, Rockville MD, June 21, 2022 (GLOBE NEWSWIRE) -- According to a recently published Fact.MR study, the Asia Pacific Medical Foods market is projected to grow at a CAGR of 6.5% from 2022...
Medical Foods Market Valuation to Hit USD 30.2 Billion by 2030 at 6.2% CAGR - Report by Market Research Future (MRFR)
20. Juni 2022 05:30 ET
|
Market Research Future
New York, USA, June 20, 2022 (GLOBE NEWSWIRE) -- Medical Foods Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Medical Foods Market Information...
Human Microbiome Market is expected to foster up to a landmark of USD 1318.72 Million by 2030 with a CAGR value of around 31.08%.
24. Mai 2022 10:39 ET
|
STRATEGIC MARKET RESEARCH LLP
New York, United States, May 24, 2022 (GLOBE NEWSWIRE) -- A Human Microbiome comprises archaea, viruses, bacteria, & eukaryotes which reside within & outside our body system. These organisms...
Guardion Health Sciences, Inc. Announces Proposed Public Offering
17. Februar 2022 09:00 ET
|
Guardion Health Sciences, Inc.
HOUSTON, TEXAS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported...
Guardion Announces Virtual Annual Meeting of Stockholders
11. September 2020 17:20 ET
|
Guardion Health Sciences, Inc.
Annual stockholder meeting scheduled for Thursday, October 29, 2020 San Diego, California, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc.(“Guardion” or the...
Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark
15. Juli 2020 09:00 ET
|
Guardion Health Sciences, Inc.
The Only Computer Vision Testing Device to Combine Standardized Contrast Sensitivity Testing with a Full Suite of Clinical Vision Tests San Diego, California, July 15, 2020 (GLOBE NEWSWIRE) --...
Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease
08. Juli 2020 08:45 ET
|
Guardion Health Sciences, Inc.
Patent Application Will Add to Guardion’s Intellectual Property Portfolio San Diego, California, July 08, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”)...